News
Candel’s pivotal phase 3 clinical trial in prostate cancer was conducted under a SPA agreed with the FDA. The FDA has also granted Orphan Drug Designation to CAN-2409 for the treatment of PDAC.
In the current ongoing phase 3 trial, ... Butler J, Miller V, Harrison SA. Integrating liver endpoints in clinical trials of cardiovascular and kidney disease. Nat Med 2024;30:2423-2431. Crossref ...
Brensocatib is an oral, selective, competitive, and reversible inhibitor of DPP-1. 19 In the phase 2 WILLOW trial involving adults with bronchiectasis, treatment with a 10-mg or 25-mg dose of ...
4D Molecular Therapeutics has initiated its first Phase 3 trial for 4D-150 in wet AMD and expanded its clinical pipeline. Quiver AI Summary. 4D Molecular Therapeutics (4DMT) has announced ...
Adial’s Phase 3 trial for AD04 will target genotype-specific subgroups of heavy drinkers with Alcohol Use Disorder. The trial is expected to launch in late 2025, with interim analyses ...
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans Provided by GlobeNewswire Jul 9, 2025, 12:35:00 PM.
A second phase 3 pivotal clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia met its primary and key secondary endpoints, according to a press ...
Phase 3 HIV Treatment Switch Studies: Key Findings From Recent Clinical Trials. Author(s): Sharon Walmsley, CM, MD, FRCPC .
Professor of neurology at UCLA and a co-principal investigator, Dr. Steven Cramer, MD affirms, “Reaching Phase 3 in a clinical trial of this scale is a hard-won milestone that has been twelve ...
The Phase 3 AFFIRM-AL clinical trial was a global, double-blind, placebo-controlled, time-to-event clinical trial that enrolled 207 newly diagnosed, treatment naïve patients with Mayo Stage IV AL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results